GREAT POINT PARTNERS I LP
CIK 1349965 · last filed 2015-07-16
GREAT POINT PARTNERS I LP is a corporate insider who has filed 23 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for CNXR, was dated Jul 16, 2015. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. The firm reports its address in Greenwich, CT. 4 SEC filings were submitted jointly with GREAT POINT PARTNERS LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
23
-$1.87M
Filer Profile
165 MASON STREET, 3RD FLOOR
GREENWICH, CT 06830
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CONNECTURE INC (CNXR) Delisted | 10%+ Owner | 4,163,725 | — | — | $0 | 1 | 2015-07-16 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | 10%+ Owner | 48,481 | — | — | -$1.87M | 22 | 2009-08-18 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-16 | CONNECTURE INC (CNXR) Delisted | Gift (G) | −60,000 | $0 | EDGAR |
| 2009-08-18 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −5,419 | -$27.2K | EDGAR |
| 2009-08-14 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −1,099 | -$5.5K | EDGAR |
| 2009-08-12 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −4,400 | -$22.1K | EDGAR |
| 2009-08-10 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −7,679 | -$38.9K | EDGAR |
| 2009-08-06 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −7,700 | -$38.6K | EDGAR |
| 2009-08-04 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −1,700 | -$8.5K | EDGAR |
| 2009-07-31 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −13,700 | -$69.3K | EDGAR |
| 2009-07-29 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −12,400 | -$64.5K | EDGAR |
| 2009-07-27 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −78,955 | -$411.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.